The FDA has approved emergency use of a third COVID-19 vaccine from Johnson & Johnson’s Janssen Biotech unit, The post FDA clears third emergency COVID-19 vaccine...
Friday the FDA Advisory Panel voted unanimously (22-0) to endorse the (one-shot, no mRNA) J&J.
A panel of expert advisers to the U.S. Food and Drug Administration began a meeting to discuss Johnson & Johnson’s one-dose COVID-19 vaccine on Friday, setting...
The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to...
Altimmune is among the biotechs trying to find more convenient delivery alternatives for COVID-19 vaccines
A transcript of The Conversation Weekly podcast episode #3.
J&J said its EUA will be based on topline efficacy and safety data from the nearly 44,000-patient Phase III ENSEMBLE trial
Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for The post J&J asks FDA for emergency clearance...
Britain launched a trial to assess the immune responses generated if doses of the Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc are combined in a...
Both vaccines appear to reduce the risk of developing COVID-19, and so could be approved later this year.
Russia's "Sputnik V" Vaccine 92% Effective Against "Symptomatic" COVID Cases As it turns out, the Kremlin wasn't embellishing when it first said its COVID vaccine, developed...
Vaccines that use harmless viruses as a delivery mechanism are vulnerable to being attacked by our immune system – but experimenting with how they are given...
Vaccines that use harmless viruses as a delivery mechanism are vulnerable to being attacked by our immune system – but experimenting with how they are given...
Johnson & Johnson published interim Phase I/IIa data in the New England Journal of Medicine showing the company's single-dose Covid-19 vaccine candidate created an immune response
US stocks are modestly higher as investors await details of President-elect Biden’s multi-trillion-dollar stimulus package, further clues if some Fed members are becoming a little bit...
What normally takes decades has been achieved in 12 months, without cutting corners.
Credit: Image: Karim Rafie “The findings provide an increased understanding of how the virus gets through the stomach and intestinal system. Continued research can provide answers...
Scientists and government sources claimed today that Johnson & Johnson’s single-jab COVID-19 vaccine could be given emergency use authorization as early as next month, according to...
After delaying its decision earlier this week, the EMA announced it has formally recommended authorizing Moderna’s Covid-19 vaccine
It may be two months before Moderna and the NIH can conclude whether they can halve their vaccine dose and provide the same level of protection
More than 3.1 billion doses have been ordered worldwide of the Oxford-AstraZeneca vaccine, providing a ray of hope in the fight against the pandemic.
UK First To Approve Astra-Zeneca Vaccine As "Tier 4" Lockdowns Expanded Even as regulators in the EU opt to give the approval process for the adenovirus-vector...
The UK has approved AstraZeneca and Oxford University’s COVID-19 vaccine AZD1222 in another significant step forward in the The post AZ COVID-19 vaccine cleared in UK,...
The UK’s COVID-19 immunization program could get a speed boost, with the country’s drugs regulator expected to make a ruling on AstraZeneca
Once one of the hottest brands in biotech, Patrick Soon-Shiong’s next-gen cancer brainchild NantKwest has taken its lumps in recent years with little to show from...
CNBC Transcript: Dr. Anthony Fauci speaks with CNBC ’s Meg Tirrell live during the CNBC Healthy Returns Livestream today and gives his predictions for coronavirus after...
AstraZeneca, which is jointly developing a Covid-19 vaccine with the University of Oxford, plans to begin clinical trials testing the company's vaccine in combination with Russia’s...
British drugmaker AstraZeneca is already running behind early competitors in the hunt for a Covid-19 vaccine with interim data that have received less-than-stellar feedback. With those...
Paul Peter Tak has done it all: From a professorship in his native Netherlands to the head of immunoInflammation R&D at GlaxoSmithKline, from leading small biotechs...
Though the White House is planning on hosting a “Vaccine Summit” on Tuesday, two major players will not be attending. Pfizer and Moderna have both reportedly...